{"title":"Establishment of Long-Term Expansion Culture for Primary Murine Nasopharyngeal Cells.","authors":"Xuan Liu, Yuxi Tian, Yuxia Zou, Yuanfeng Fu, Chenglong Zheng, Tingting Duan, Mingyue Chen, Jiaolin Bao, Xiaofeng Wang, Ren-Bo Ding, Xuejun Zhou","doi":"10.1089/ten.tec.2025.0057","DOIUrl":null,"url":null,"abstract":"<p><p>The nasopharynx constitutes a critical component of the respiratory tract. Nasopharyngeal diseases are closely related to nasopharyngeal epithelial cells (NECs). Considering the current paucity of appropriate cell models for studying nasopharynx-related diseases, there is an urgent need to develop a simple and efficient method for the long-term culture and robust expansion of primary NECs. In this study, we employed the NEC medium supplemented with Wnt3a, R-spondin, Noggin, and other growth factors to stimulate the proliferation of nasopharyngeal epithelial stem cells and maintain their self-renewal state, enabling long-term culture. Leveraging this strategy, we successfully developed a simplified and efficient method for long-term culture of primary murine NECs. The NEC medium provided a selective advantage for stably expanding cytokeratin 5- and epithelial membrane antigen-positive epithelial cells rather than alpha-smooth muscle actin-marked fibroblasts and prevented epithelial-mesenchymal transition as evidenced by continuously strong E-cadherin expression and being negative for vimentin. The established NEC line exhibited stable long-term proliferation with no evident signs of senescence. We also confirmed the nontumorigenic nature of the established nasopharyngeal cell line in mice. Our findings from this study provided a valuable cellular tool for investigating nasopharyngeal epithelial-related diseases and developing therapeutic strategies.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue engineering. Part C, Methods","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/ten.tec.2025.0057","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0
Abstract
The nasopharynx constitutes a critical component of the respiratory tract. Nasopharyngeal diseases are closely related to nasopharyngeal epithelial cells (NECs). Considering the current paucity of appropriate cell models for studying nasopharynx-related diseases, there is an urgent need to develop a simple and efficient method for the long-term culture and robust expansion of primary NECs. In this study, we employed the NEC medium supplemented with Wnt3a, R-spondin, Noggin, and other growth factors to stimulate the proliferation of nasopharyngeal epithelial stem cells and maintain their self-renewal state, enabling long-term culture. Leveraging this strategy, we successfully developed a simplified and efficient method for long-term culture of primary murine NECs. The NEC medium provided a selective advantage for stably expanding cytokeratin 5- and epithelial membrane antigen-positive epithelial cells rather than alpha-smooth muscle actin-marked fibroblasts and prevented epithelial-mesenchymal transition as evidenced by continuously strong E-cadherin expression and being negative for vimentin. The established NEC line exhibited stable long-term proliferation with no evident signs of senescence. We also confirmed the nontumorigenic nature of the established nasopharyngeal cell line in mice. Our findings from this study provided a valuable cellular tool for investigating nasopharyngeal epithelial-related diseases and developing therapeutic strategies.
期刊介绍:
Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications that repair or regenerate portions or whole tissues. This multidisciplinary journal brings together the principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine. Tissue Engineering is divided into three parts, providing a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues.
Tissue Engineering Methods (Part C) presents innovative tools and assays in scaffold development, stem cells and biologically active molecules to advance the field and to support clinical translation. Part C publishes monthly.